Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis

• Главные авторы: A. Lo Gullo (Автор), G. Mandraffino (Автор), C.O. Aragona (Автор), A. Molica Colella (Автор), A. Saitta (Автор), E. Imbalzano (Автор)
• Формат: ‌
• Опубликовано: PAGEPress Publications, 2017-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Takayasu arteritis (TA) is a chronic inflammatory disease of unknown origin that involves large and mediumsized arteries, primarily the aorta and its major branches. TA is a therapeutic challenge because corticosteroids and conventional immunosuppressive agents are not always effective or safe. Inte...